Saturday 7 November 2026 Export NVCT’s income statement to Excel — free account

Nuvectis Pharma, Inc.

NVCT Healthcare Biotechnology

EPS: −131.9%
Free cash flow: −34.6%

Quarter to September 2026, against a year earlier

Insider buying

20.81 3.05 +17.17%

Follow NVCT

Alert me

Market cap: $579.8M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	(205.30%)	(168.24%)	(233.30%)	(66.98%)
ROA Full definition →		(114.76%)	(106.54%)	(122.61%)	(57.20%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(156.80%)	(208.08%)	(333.35%)	(39.84%)
Free Cash Flow per Share Full definition →		(0.73)	(0.78)	(0.83)	(1.37)
Free Cash Flow Full definition →		(16.01)	(18.35)	(19.51)	(40.29)
Other line items
Cash ROIC Full definition →		(31.99%)	(46.62%)	(62.45%)	(15.07%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.55	0.62	0.64	0.80
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(0.73)	(0.78)	(0.83)	(1.37)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026